Advisory Services Network, LLC Myriad Genetics Inc Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 24, 2021	SELL	$19.92 - $31.6 $4,980 - $7,900	-250 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$12.16 - $19.77 $3,441 - $5,594	-283 Reduced 53.1%	250 $5,000
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $5,996 - $7,861	533 New	533 $7,000
Q2 2020 Aug 10, 2020	SELL	$10.69 - $16.49 $11,577 - $17,858	-1,083 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$20.93 - $35.1 $11,574 - $19,410	553 Added 104.34%	1,083 $29,000
Q2 2019 Aug 01, 2019	BUY	$22.67 - $35.0 $6,347 - $9,800	280 Added 112.0%	530 $0
Q3 2018 Nov 02, 2018	SELL	$37.57 - $50.34 $20,287 - $27,183	-540 Reduced 68.35%	250 $12,000
Q2 2018 Jul 27, 2018	SELL	$27.75 - $40.17 $5,550 - $8,034	-200 Reduced 20.2%	790 $34,000
Q3 2017 Oct 12, 2017	SELL	$24.01 - $36.2 $12,005 - $18,100	-500 Reduced 33.56%	990 $36,000
Q2 2017 Aug 17, 2017	BUY	N/A	1,490	1,490 $39,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.